Ovarian Cancer Trial, Recruiting NCT07616310 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07616310
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to take part and able to sign a consent form
  • You are between 18 and 70 years old
  • You have been diagnosed with epithelial ovarian cancer (a specific type of ovarian cancer) and are scheduled for initial surgery to remove as much of the tumor as possible, with or without the cancer having spread within the abdomen or to other parts of the body (at stage IIB or higher)
  • A recent colonoscopy showed no cancer growing into the inner lining of the bowel
  • A pre-surgery scan using an enhanced pelvic MRI shows the tumor is affecting the surface of the intestine and/or a large part of the tissue connecting the intestines (the mesentery)
  • You are reasonably active and able to care for yourself, based on a standard medical fitness score (confirm with trial site)
  • You are considered fit enough to safely undergo general anesthesia and surgery, based on a standard anesthesia risk score (confirm with trial site)

Who may not be able to join:

  • You have had another type of cancer in the past, or you are currently receiving treatment for any other cancer
  • You have serious health conditions that mean you would not be able to safely tolerate surgery
  • Your ovarian cancer was only discovered unexpectedly during emergency surgery
  • You are currently taking part in another clinical trial
  • This would be a second surgery to reduce your tumor (not your first)
  • You have previously had radiation therapy to your abdomen or pelvis

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13732238958

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 January 2024
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression-free survival(PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov